Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Dyskinesia, Heterotaxy and Congenital Heart Disease

View source ↗

Summary

Clinical trial update from NIAID indicates the study on primary ciliary dyskinesia, including Kartagener syndrome, and related congenital heart disease with sit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ciliary Dyskinesia, Primary, Kartagener Syndrome | Status: COMPLETED